Prodrugs Medicinal Chemistry I 1. Prodrugs Are inactive compounds converted to the active form in...
-
Upload
horace-oneal -
Category
Documents
-
view
237 -
download
1
Transcript of Prodrugs Medicinal Chemistry I 1. Prodrugs Are inactive compounds converted to the active form in...
1
Prodrugs
Medicinal Chemistry I
2
Prodrugs
Are inactive compounds converted to the active form in vivo.
Useful for drugs with undesirable physicochemical property.
3
Undesirable Properties
• Physical Properties:a) Poor aqueous solubilityb) Low lipophilicityc) Chemical instabilityd) Acid Sensitivitye) Poor Membrane Permeability (poor absorption)f) Toxicity (non-selective bioactivity)g) Bad Tasteh) Short Duration of Actioni) Non-site specific
4
Prodrugs activation mechanisms
• Variety of mechanisms by which prodrug can be converted into active drug:1. Metabolizing enzymes (phosphotase, esterases, peptidase)
• Interpatient variable
2. Chemical activation (Hydrolysis, decarboxylation, light activation)• Stability issues
3. Mixture of both
• Two important points:1. The prodrug should be effectively converted to the active form once
absorbed in the blood.2. Cleavable groups are non toxic.
Not all prodrugs are activated by metabolic enzymes. Photodynamic therapy involve the use of an external light to activate prodrugs.
6
Prodrugs classification
• Can be classified into three categories: 1. Carrier-linked prodrugs
- Carrier-linked prodrugs are drugs that have been attached through a metabolically labile linkage to another molecule, the so-called promoiety, which is not necessary for activity but may impart some desirable property to the drug
7
Prodrugs classification
2. Mutual prodrugs - In this type, both the drug and the
carrier has activity
8
Produrgs classification
3. Bioprecursor prodrugs- contain no promoiety but rather rely on metabolism to introduce the functionality necessary to create an active species
9
Carrier-linked prodrugs Prodrugs functional groups
10
Prodrugs functional groups - Esters The most common type of prodrug because of the ease with
which the ester can be hydrolyzed or formed.
Esterase enzymes present in plasma and other tissues that are capable of hydrolyzing a wide variety of ester linkages
Can add lipophilicity or hydrophilicity to the drug
Increasing lipophilicity of the compound may yield a number of benefits, including increased absorption, decreased dissolution in the aqueous environment of the stomach, longer duration of action, and reducing bad taste
11
Improve membrane permeability• Problem: - Epinephrine is poorly absorbed through eye tissues
- Catechols are unstable• Solution: The increased lipophilicity relative to epinephnine allows the
drug to move across the membrane of the eye easily and achieve higher intraocular concentrations
• The steric bulk of pivalic acid slows down the hydrolysis
HN
OH
OH
HO
Epinephrinepoor corneal membrane penetration
HN
OH
O
O
O
O
Dipivefrinbetter corneal penetration
Used in Glaucoma
12
Improve Membrane Permeability Ampicillin is poorly absorbed from the GI tract
(~30% absorbed)WHY??? The carboxylic acid functional group (COOH): Binds the drug to a receptor via ionic or hydrogen
bonding. An ionizable group may prevent drug from
crossing a fatty cell membrane.Solution: Convert the acid function to an ester moiety. The less polar ester can cross fatty cell
membranes. The ester group will be hydrolyzed back to the
free acid by the esterase in the blood.
13
Ampicillin activation In Vivo
Esterase
Esterase
14
Masking bad taste• Problem: Water soluble drugs when dissolve in the mouth
could lead to bad taste- This cause low compliance (pediatric)
• Solution: A prodrug with reduced water solubility does not dissolve to any appreciable extent in the mouth and, therefore, does not interact with taste receptors.
Prodrugs for stability• Problem: propanolol undergo extensive first
pass metabolism (glucuronidation)• Solution: adding ester group on the alcohol
will protect it from metabolismO
OH
NH
Propranolol
Fisrt pass metabolism
O
O
NH
OOH
OBlood esterase
O
OH
NH
PropranololActive antihypertensive agent
O
O
NH
Propranolol O-glucuronide
OO
OH
OHHO
HO
Propanolol hemisuccinate
No fisrt pass metabolism by O-glucuronidation
Prodrugs for stability
OHO
N
O
OH
Naltrexoneused in the treatment of opioid addictionundergo extensive first-pass metabolism
OO
N
O
OH
OO
N
O
OH
OO
NO2
O
ONaltrexone anthranilate45 folds better orally available
Naltrexone acetylsalicylate28 folds better orally available
17
Increasing hydrophilicity• Increase the water solubility of drugs, making them more
suitable for parenteral or oral administration when high water solubility is desirable
DrugO
O
Succinate esterIncreased water solubilityRapid Hydrolysis ( Relatively Unstable)
Drug
OS
O
O
ODrug
OP
O
O
O
Sulfate and phosphate esterIncreased water solubilityMore stable
OH
O
Clindamycin Phosphate
Improve membrane permeabilityPeptide carrier systems
NH
N
N
O
NH2N
OO
O
H2N H
L-valyl
Valaciclovir
NH
N
N
O
NH2N
OHO
Intestinal
absorption
Acyclovir in blood
19
Improve membrane permeabilityPeptide carrier systems
Prodrug
Protein Carrier in BBB (Blood Brain Barrier)
Drugs with amine moiety
• The amide derivative is not a suitable choice in most of the case (WHY?)….Stable bond toward hydrolysis compared to the ester bond.
DrugHN
O
OR
DrugHN
O
R
Drug N
Carbamate Amide
Imine
Ar
Drug N
N Ar
Azo
21
Drugs with amine moietyProdrug to increase lipophilicity
NNH2
OOH
F
ProgabideAnti-convulsant agent
H2NOH
O
GABAinhibitory neurotransmitter
Drugs with amine moietyProdrugs to increase water solubility
H2N
O
O
Benzocaine
NH
O
O
O
H3N
R
Benzocaine coupled with amino acidionized at physiological pH\
better water solubility
23
Prolong The ActivityDiazepam
Prodrug
•Sustained Action•N-demethylation Metabolism
Hexobarbitone
N NH
Me
O O
O
Me
Cyclophosphoramide for phosphoramide mustard (anticancer agent)
Prodrugs to mask toxicity and side effects
Cyclophosphoramide• Non toxic• Orally active
Phosphoramide mustard• Alkylating agent
1. Cyt P450 2. Phosphoramidase
(liver)
O
P
NH O
N
Cl
Cl
HO
P
Cl
Cl
N
OH2N
25
Azo prodrugs from amine
NHN
SO O
N N
OH
COOH
SulfasalazineUsed in ulcerative colitis
Azoreductase
released by colorectal bacteria
NHN
SO O
NH2
H2N
OH
COOH
Sulfapyridine
Aminosalicylic Acid
Prodrugs used to target drugs
Example:Hexamine
• Stable and inactive at pH>5• Stable at blood pH• Used for urinary infections where pH<5 • Degrades at pH<5 to form formaldehyde (antibacterial agent)
NN
N
N
27
Bioprecursor prodrugs
• Bioprecursor prodrugs mostly use either oxidative or reductive activation reactions.
• The main activation pathways are:1) Proton activation.2) Hydrolytic activation3) Elemination activation4) Oxidative activation5) Reductive activation6) Nucleotide activation7) Phosphorylation activation8) Sulfation activation9) Decarboxylation activation
28
Reduce toxicityNabumetone
29
Reduce toxicityIdoxuridine phosphorylation
30
Most other antiviral requires the same activation mechanism
N
NN
N NH2HO
OHPenciclovir
Viralthymidinekinase
N
NN
N NH2P O
OH
Cell kinases
N
NN
N NH2O
OH
PPP
31
Proton Pump Inhibitor ActivationOmeprazole
32
33
Bioluminescent Red Tide
34